Searching for the Fsdpharma.com login page? Here you will find the most up-to-date links to login pages related to fsdpharma.com. Also, we have collected additional information about fsdpharma.com login for you below.
Category | F |
---|---|
Domain name | fsdpharma.com |
DNS servers | alec.ns.cloudflare.com,irma.ns.cloudflare.com |
IP | 104.25.246.30 |
Country by IP | US |
Country by HTML code | US |
Alexa traffic rank | 608833 |
Renowned clinical team led by Dr. Lakshmi P. Kotra who is the recipient of the Julia Levy Award, is a Senior Scientist at Krembil Brain Institute, as well as University Health Network (UHN), and Professor of Medicinal Chemistry at the University of Toronto.Dr. Kotra serves as CEO of FSD Pharma’s wholly owned subsidiary, Lucid Psycheceuticals Visit website
SECURITIES CLASS ACTION SETTLEMENT. ANNE MILLER V. FSD PHARMA, INC. CV-19-614981-00CP. This claims administration website was updated on June 2, 2022. Dear Claimants, Thank you for your patience as we progress through the claims administration. We apologize for the delay in making Distributions to Authorized Claimants. Visit website
Orders for medicinal cannabis can be placed on fvpharma.com. TORONTO, Aug. 21, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") today announced the launch of its online ordering system for the direct fulfillment of medicinal cannabis orders. Visit website
TORONTO--(BUSINESS WIRE)-- FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that it has entered into an Equity Distribution Agreement dated February 11, 2021 (the "Sales Agreement") with A.G.P./Alliance Global Partners (the "Sales Agent").Under the Sales Agreement the Company may, at its discretion and from … Visit website
FSD Pharma Inc, Toronto, Ontario. 66 likes · 391 talking about this. FSD Pharma Official Facebook Page Development of Novel Solutions for Brain and... Visit website
FSD Pharma Inc. Mailing Address: 243 College St. Suite 101 Toronto, Ontario M5T1R5: Head Office Address: 199 Bay St. Suite 4000 Toronto, Ontario M5L 1A9 Visit website
Shareholders’ Canadian Counsel: Albert Pelletier and Andrew Morganti, Morganti & Co. Claim Administrator: Trilogy Class Action Services. Attention: FSD Class Action Settlement. 117 Queen Street, P.O. Box 1000, Niagara-on-the-Lake, Ontario L0S 1J0. Tel: 1-877-400-1211. Visit website
TORONTO--(BUSINESS WIRE)-- FSD Pharma Inc. (“FSD Pharma”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that Dr. Zohar Koren, CEO of its Strategic Partner SciCann Therapeutics (“SciCann”) and Head of its Scientific Advisory Board, will present at the International Cannabinoid-Derived Pharmaceuticals Summit (“iCDP Summit”) in Boston, on … Visit website
Zeeshan Saeed, Founder, President and Executive Co-Chairman of the Board, FSD Pharma Inc. Zsaeed@fsdpharma.com (416) 854-8884 Investor Relations: ir@fsdpharma.com, skilmer@fsdpharma.com www ... Visit website
FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development. Please visit www.fsdpharma.com for more information. Forward-Looking Information. Certain statements contained in this press release constitute forward-looking information. Visit website
Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name FSD Pharma Inc. Stock Symbol NASDAQ:HUGE. Company Type For Profit. Contact Email info@fsdpharma.com. Phone Number (905) 686-7079. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharmas management’s mission is ... Visit website
FSD Pharma is a biotech company focused on the development of indoor-grown pharmaceutical-grade cannabis. It offers cannabinoid-based treatments for certain central nervous system disorders and autoimmune diseases of the skin, GI tract and musculoskeletal system, including chronic pain. Visit website
TORONTO--(BUSINESS WIRE)-- FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) in response to Therapix Biosciences’ termination of the company’s binding letter of intent (LOI) to be acquired by FSD Pharma, Dr. Raza Bokhari, Executive Co-Chairman of the Board of FSD Pharma, released the following statement: Visit website
FSD-Pharma General Information Description. FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. Visit website
Zeeshan Saeed, Founder, President and Executive Co-Chairman of the Board, FSD Pharma Inc. Email: Zsaeed@fsdpharma.com Telephone: (416) 854-8884 Investor Relations: Email: ir@fsdpharma.com, info ... Visit website
TORONTO, April 08, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and ... Visit website